Yang-Xin Fu

5.7k total citations · 3 hit papers
30 papers, 3.8k citations indexed

About

Yang-Xin Fu is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Yang-Xin Fu has authored 30 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 17 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Yang-Xin Fu's work include Cancer Immunotherapy and Biomarkers (13 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (10 papers). Yang-Xin Fu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (10 papers). Yang-Xin Fu collaborates with scholars based in United States, China and France. Yang-Xin Fu's co-authors include Min Luo, Jinming Gao, Xiang Chen, Zhijian J. Chen, Zhaohui Wang, Ralph R. Weichselbaum, Zhida Liu, Jayanthi Lea, Liufu Deng and Hua Liang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Immunity.

In The Last Decade

Yang-Xin Fu

30 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A STING-activating nanovaccine for cancer immunotherapy

2017 752 citations Min Luo, Hua Wang et al. Nature Nanotechnology profile →
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis

2020 307 citations Lang Rao, Lei Wu et al. Nature Communications profile →
Prolonged activation of innate immune pathways by a polyvalent STING agonist

2021 240 citations Suxin Li, Min Luo et al. Nature Biomedical Engineering profile →

Peers

Countries citing papers authored by Yang-Xin Fu

Since Specialization

Citations

This map shows the geographic impact of Yang-Xin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang-Xin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang-Xin Fu more than expected).

Fields of papers citing papers by Yang-Xin Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang-Xin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang-Xin Fu. The network helps show where Yang-Xin Fu may publish in the future.

Co-authorship network of co-authors of Yang-Xin Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yang-Xin Fu. A scholar is included among the top collaborators of Yang-Xin Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang-Xin Fu. Yang-Xin Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prolonged activation of innate immune pathways by a polyvalent STING agonist breakdown → 2021 ·Nature Biomedical Engineering ·Suxin Li, Min Luo, Zhaohui Wang, Qiang Feng, Jonathan Wilhelm, Xu Wang, Wei Li, Jian Wang, Agnieszka Cholka, Yang-Xin Fu, Baran D. Sumer, Hongtao Yu, Jinming Gao	240
2	Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells 2021 ·Nature Communications ·Ryan Kolb, Umasankar De, Sajid Khan, Yuewan Luo, Myung‐Chul Kim, Haijun Yu, Chaoyan Wu, Jiao Mo, Xin Zhang, Peiyi Zhang, Xuan Zhang, Nicholas Borcherding, (unknown), Yang-Xin Fu, Song Guo Zheng, Dorina Avram, Guangrong Zheng, Daohong Zhou, Weizhou Zhang	42
3	Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Casey Moore, (unknown), Wei‐Min Chen, Benjamin P.C. Chen, Chuanhui Han, Michael D. Story, Todd A. Aguilera, Laurentiu M. Pop, Raquibul Hannan, Yang-Xin Fu, Debabrata Saha, Robert Timmerman	67
4	CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells 2020 ·Frontiers in Immunology ·Linxia Zhang, Anli Zhang, Jun Xu, (unknown), Chao Qiu, Lingyan Zhu, Weihui Fu, Ying Wang, Lilin Ye, Yang-Xin Fu, Chen Zhao, Xiaoyan Zhang, (unknown), (unknown)	18
5	Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling 2020 ·Nature Immunology ·Chuanhui Han, Zhida Liu, Yunjia Zhang, Aijun Shen, Chunbo Dong, Anli Zhang, Casey Moore, Zhenhua Ren, Changzheng Lu, Xuezhi Cao, Chun‐Li Zhang, Jian Qiao, Yang-Xin Fu	116
6	Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling 2020 ·Nature Immunology ·Chuanhui Han, Zhida Liu, Yunjia Zhang, Aijun Shen, Chunbo Dong, Anli Zhang, Casey Moore, Zhenhua Ren, Changzheng Lu, Xuezhi Cao, Chun‐Li Zhang, Jian Qiao, Yang-Xin Fu	2
7	Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis breakdown → 2020 ·Nature Communications ·Lang Rao, Lei Wu, Zhida Liu, Rui Tian, Guocan Yu, Zijian Zhou, Kuikun Yang, (unknown), Anli Zhang, (unknown), Wenjing Sun, Xu Han, Jingya Guo, Andrew Li, Hongmin Chen, Zhi‐Jun Sun, Yang-Xin Fu, Xiaohong Chen	307
8	The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy 2019 ·Nature Communications ·(unknown), Li Zhang, (unknown), (unknown), (unknown), Hong Yu, (unknown), (unknown), Fan Liang, Chen Zhang, (unknown), Zhihua Liu, Yang-Xin Fu, Guang‐Biao Zhou	159
9	Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity 2019 ·Science Immunology ·Zhida Liu, Chuanhui Han, Chunbo Dong, Aijun Shen, Eric J. Hsu, Zhenhua Ren, Changzheng Lu, Longchao Liu, Anli Zhang, (unknown), Yang Pu, Yang Wang, Mingyi Chen, Jian Qiao, Yang-Xin Fu	35
10	Tumor-reprogrammed resident T cells resist radiation to control tumors 2019 ·Nature Communications ·Ainhoa Arina, Michael A. Beckett, Christian Fernandez, Wenxin Zheng, Sean P. Pitroda, Steven J. Chmura, Jason J. Luke, (unknown), Yuzhu Hou, Byron Burnette, Helena J. Mauceri, Israel Lowy, Tasha N. Sims, Nikolai N. Khodarev, Yang-Xin Fu, Ralph R. Weichselbaum	161
11	NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance 2019 ·Nature Communications ·Xiaoguang Li, Zhida Liu, Anli Zhang, Chuanhui Han, Aijun Shen, Lingxiang Jiang, David A. Boothman, Jian Qiao, Yang Wang, Xiumei Huang, Yang-Xin Fu	74
12	Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance 2018 ·Nature Communications ·Yong Liang, Haidong Tang, Jingya Guo, Xiangyan Qiu, (unknown), Zhenhua Ren, Zhichen Sun, Yingjie Bian, Lily Xu, Hairong Xu, (unknown), Yanfei Han, Haidong Dong, Hua Peng, Yang-Xin Fu	69
13	Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy 2018 ·Methods in molecular biology ·Haidong Tang, Xiangyan Qiu, (unknown), Yang-Xin Fu	11
14	Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression 2017 ·Cancer Immunology Research ·Jing Liao, Yan Luan, Zhenhua Ren, Xiaojuan Liu, (unknown), Hairong Xu, Zhichen Sun, Kaiting Yang, Hua Peng, Yang-Xin Fu	13
15	A STING-activating nanovaccine for cancer immunotherapy breakdown → 2017 ·Nature Nanotechnology ·Min Luo, Hua Wang, Zhaohui Wang, (unknown), Zhigang Lu, Yang Li, Mingjian Du, Gang Huang, Chensu Wang, Xiang Chen, Matthew R. Porembka, Jayanthi Lea, Arthur E. Frankel, Yang-Xin Fu, Zhijian J. Chen, Jinming Gao	752
16	Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine 2017 ·Cell Discovery ·Zhida Liu, (unknown), Qin Yan, Zihao Wang, (unknown), Xiuli Wei, (unknown), Qicheng Li, Hang Zhou, Wenjun Wang, Yang-Xin Fu, Mingzhao Zhu, Wei Liang	45
17	Host STING-dependent MDSC mobilization drives extrinsic radiation resistance 2017 ·Nature Communications ·Hua Liang, Liufu Deng, Yuzhu Hou, Xiangjiao Meng, Xiaona Huang, Enyu Rao, Wenxin Zheng, Helena J. Mauceri, Matthias Mack, Meng Xu, Yang-Xin Fu, Ralph R. Weichselbaum	366
18	Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling 2017 ·Immunity ·Meng Xu, Pu Yang, Dali Han, Yaoyao Shi, Xuezhi Cao, Hua Liang, Xiang Chen, Xiao-Dong Li, Liufu Deng, Zhijian J. Chen, Ralph R. Weichselbaum, Yang-Xin Fu	241
19	Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth 2016 ·Stem Cells Translational Medicine ·Huilin Zheng, (unknown), Jiaying Shen, Liang Xu, Shu Wang, Yang-Xin Fu, Weimin Fan	23
20	The regulation of T cell homeostasis and autoimmunity by T cell–derived LIGHT 2001 ·Journal of Clinical Investigation ·Jing Wang, James C. Lo, (unknown), Ping Yu, (unknown), Yang Wang, Koji Tamada, Lieping Chen, Yang-Xin Fu	203

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact